Clinical Trials Browser

Phase 2 × MORAb-202 × Clear all

NCT05577715 2025-09-04

A Study of MORAb-202 in Participants With Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC) Adenocarcinoma (AC)

Phase 2 Terminated

31 enrolled 12 charts

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung